| Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. F Diurno, FG Numis, G Porta, F Cirillo, S Maddaluno, A Ragozzino, ... European Review for Medical & Pharmacological Sciences 24 (7), 2020 | 389 | 2020 |
| Editorial–Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet M Ceccarelli, M Berretta, EV Rullo, G Nunnari, B Cacopardo European review for medical and pharmacological sciences 24 (5), 2781-2783, 2020 | 193 | 2020 |
| The role of the hospital environment in the healthcare-associated infections: a general review of the literature. A Facciola, GF Pellicano, G Visalli, IA Paolucci, E VENANZI RULLO, ... European Review for Medical & Pharmacological Sciences 23 (3), 2019 | 103 | 2019 |
| Silent COVID-19: what your skin can reveal C Guarneri, EV Rullo, P Pavone, M Berretta, M Ceccarelli, A Natale, ... The Lancet Infectious Diseases 21 (1), 24-25, 2021 | 93 | 2021 |
| Resveratrol in cancer patients: from bench to bedside M Berretta, A Bignucolo, R Di Francia, F Comello, G Facchini, ... International journal of molecular sciences 21 (8), 2945, 2020 | 78 | 2020 |
| Congenital cytomegalovirus infection: current strategies and future perspectives. D Buonsenso, D Serranti, L Gargiullo, M Ceccarelli, O Ranno, P Valentini European Review for Medical & Pharmacological Sciences 16 (7), 2012 | 76 | 2012 |
| Multiple effects of ascorbic acid against chronic diseases: Updated evidence from preclinical and clinical studies M Berretta, V Quagliariello, N Maurea, R Di Francia, S Sharifi, G Facchini, ... Antioxidants 9 (12), 1182, 2020 | 74 | 2020 |
| HIV‐associated psoriasis: epidemiology, pathogenesis, and management M Ceccarelli, E Venanzi Rullo, M Vaccaro, A Facciolà, F d'Aleo, ... Dermatologic Therapy 32 (2), e12806, 2019 | 70 | 2019 |
| Outbreak of COVID-19 infection in children: fear and serenity P Pavone, M Ceccarelli, R Taibi, G La Rocca, G Nunnari Eur Rev Med Pharmacol Sci 24 (8), 4572-4575, 2020 | 62 | 2020 |
| Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'aleo, M Di Rosa, ... Eur Rev Med Pharmacol Sci 21 (24), 5868-5869, 2017 | 62 | 2017 |
| Diversity of clinical appearance of cutaneous manifestations in the course of COVID‐19 C Guarneri, EV Rullo, R Gallizzi, M Ceccarelli, SP Cannavò, G Nunnari Journal of the European Academy of Dermatology and Venereology 34 (9), e449, 2020 | 58 | 2020 |
| Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives A Facciolà, G Visalli, S La Maestra, M Ceccarelli, F D’Aleo, G Nunnari, ... Environmental Toxicology and Pharmacology 65, 23-30, 2019 | 56 | 2019 |
| Transmission mode associated with coronavirus disease 2019: a review. F Vella, P Senia, M Ceccarelli, E Vitale, H Maltezou, R Taibi, A Lleshi, ... European Review for Medical & Pharmacological Sciences 24 (14), 2020 | 55 | 2020 |
| Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy P Valentini, D Buonsenso, G Barone, D Serranti, R Calzedda, ... Journal of Perinatology 35 (2), 90-94, 2015 | 49 | 2015 |
| Persistence of an intact HIV reservoir in phenotypically naive T cells EV Rullo, MR Pinzone, LM Cannon, S Weissman, M Ceccarelli, ... JCI insight 5 (20), 2020 | 45 | 2020 |
| Genetic evidence that naive T cells can contribute significantly to the human immunodeficiency virus intact reservoir: time to re-evaluate their role E Venanzi Rullo, LM Cannon, MR Pinzone, M Ceccarelli, G Nunnari, ... Clinical Infectious Diseases 69 (12), 2236-2237, 2019 | 39 | 2019 |
| Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children M Sali, D Buonsenso, P D'Alfonso, F De Maio, M Ceccarelli, B Battah, ... Journal of Infection 77 (6), 526-533, 2018 | 39 | 2018 |
| Malignant melanoma in HIV: Epidemiology, pathogenesis, and management A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'Andrea, M Coco, C Micali, ... Dermatologic Therapy 33 (1), e13180, 2020 | 38 | 2020 |
| SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome P Pavone, M Ceccarelli, S Marino, D Caruso, R Falsaperla, M Berretta, ... The Lancet Child & Adolescent Health 5 (6), e19-e21, 2021 | 37 | 2021 |
| Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors E Venanzi Rullo, M Ceccarelli, F Condorelli, A Facciolà, G Visalli, ... Molecular Medicine Reports 19 (3), 1987-1995, 2019 | 36 | 2019 |
